Cargando…

Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography

Invasive lobular carcinoma is the second most common histologic form of breast cancer, representing 5% to 15% of all invasive breast cancers. Due to an insidious proliferative pattern, invasive lobular carcinoma remains clinically and radiologically elusive in many cases. Breast magnetic resonance i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costantini, Melania, Montella, Rino Aldo, Fadda, Maria Paola, Tondolo, Vincenzo, Franceschini, Gianluca, Bove, Sonia, Garganese, Giorgia, Rinaldi, Pierluigi Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224821/ https://www.ncbi.nlm.nih.gov/pubmed/35743654 http://dx.doi.org/10.3390/jpm12060867

Ejemplares similares

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer
por: Costantini, Melania, et al.
Publicado: (2021)

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
por: Massafra, Raffaella, et al.
Publicado: (2021)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size
por: Nicosia, Luca, et al.
Publicado: (2021)

Lobular Breast Cancer Conspicuity on Digital Breast Tomosynthesis Compared to Synthesized 2D Mammography: A Multireader Study
por: Romanucci, Giovanna, et al.
Publicado: (2021)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
por: La Forgia, Daniele, et al.
Publicado: (2020)

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts
por: Rudnicki, Wojciech, et al.
Publicado: (2021)

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022)

Retrospective Comparison of Contrast-Enhanced Spectral Mammography with Digital Mammography in Assessing Tumor Size in 668 Cases of Breast Cancer
por: Lorek, Andrzej, et al.
Publicado: (2020)

Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images
por: Fanizzi, Annarita, et al.
Publicado: (2019)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
por: Romito, Alessia, et al.
Publicado: (2021)

Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis
por: Suter, Matteo Basilio, et al.
Publicado: (2020)

Radiomics Analysis on Contrast-Enhanced Spectral Mammography Images for Breast Cancer Diagnosis: A Pilot Study
por: Losurdo, Liliana, et al.
Publicado: (2019)

The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI
por: Lobbes, Marc B.I., et al.
Publicado: (2015)

Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions
por: Xing, Dong, et al.
Publicado: (2019)

Contrast‐enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients
por: Qin, Yun, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts
por: Lu, Zhongfei, et al.
Publicado: (2020)

A meta‐analysis of contrast‐enhanced spectral mammography versus MRI in the diagnosis of breast cancer
por: Xiang, Wanqing, et al.
Publicado: (2020)

Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy
por: James, Jonathan
Publicado: (2022)

Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
por: Iotti, Valentina, et al.
Publicado: (2017)

Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management
por: Houben, Ivo PL, et al.
Publicado: (2019)

Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China
por: Wang, Qingguo, et al.
Publicado: (2016)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours
por: Dominique, Caroline, et al.
Publicado: (2022)

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer
por: Zhang, Yongxia, et al.
Publicado: (2021)

Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Zhang, Kun, et al.
Publicado: (2023)

Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients
por: Feng, Lei, et al.
Publicado: (2022)

Invasive lobular carcinoma of the breast.
por: Hayes, D., et al.
Publicado: (1981)

Quantitative Breast Density in Contrast-Enhanced Mammography
por: Gennaro, Gisella, et al.
Publicado: (2021)

Contrast-Enhanced Mammography in the Diagnosis of Breast Angiosarcoma
por: Kacen, Maya Grisaru, et al.
Publicado: (2021)

Contrast enhanced mammography in breast cancer surveillance
por: Elder, Kenneth, et al.
Publicado: (2023)

A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography
por: Nicosia, Luca, et al.
Publicado: (2022)

Multimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics
por: Dołęga-Kozierowski, Bartosz, et al.
Publicado: (2022)

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study
por: Bozzini, Anna, et al.
Publicado: (2020)

The new method, the old problem – role of contrast-enhanced spectral mammography in the diagnosis of breast cancer among Polish women
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3arrdeh6t4j2uqb4e2if5d02hl